Highlights GemVax&KAEL Co.,Ltd.

Equities

A082270

KR7082270000

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
11,090 ^KRW	+0.09%		-1.86%	-16.49%

05-02	Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	CI
03-25	GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	31/08/22	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	14/06/22	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	13/06/22	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	13/06/22	CI
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	09/06/22	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	13/04/22	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	12/04/22	CI
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	18/08/21	CI
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	18/08/21	CI
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	30/03/21	CI
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	06/10/20	CI
GemVax Announces Phase II Results of GV1001 for Alzheimer's Disease Treatment at CTAD 2019	11/12/19	CI
Gem&Company acquired an additional 2.67% stake in GemVax&KAEL Co.,Ltd from Junghwa Yoon for KRW 11.2 billion.	10/07/18	CI
Hyungseok Oh acquired a 8.31% stake in KSCB Co.,Ltd. from GemVax&KAEL Co.,Ltd for KRW 10.6 billion.	28/03/17	CI
Kim, Sang-Jae, Chief Executive Officer of GemVax&KAEL Co.,Ltd signed a contract to acquire an additional 0.66% stake in GemVax&KAEL Co.,Ltd from KSCB Co.,Ltd. for KRW 2.7 billion.	06/02/17	CI
GemVax & Kael Co., Ltd. acquired 39.99% stake in Kingsmen Korea Limited for KRW 4 billion.	06/12/15	CI
GemVax & Kael Co.,Ltd. completed the acquisition of 18.2% stake in Samsung Pharmaceutical Industry Corporation Limited. from Kim Won Gyu and five related parties.	27/05/14	CI
GemVax & Kael Co.,Ltd. signed a contract to acquire a 18.2% stake in Samsung Pharmaceutical Industry Corporation Limited. from Kim Won Gyu and five related parties for KRW 12 billion.	21/05/14	CI
KB Asset Management Co., Ltd. acquired 5.2% stake in GemVax & Kael Co.,Ltd..	12/05/14	CI
GemVax & Kael Co.,Ltd. agreed to acquire the remaining 3.86% stake in KAEL-GemVax Co., Ltd. for KRW 10.6 billion.	19/01/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GemVax&KAEL Co.,Ltd.

Equities

A082270

KR7082270000

Highlights

Filters